ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
European Neuropsychopharmacology
Volume 15, Issue 4, August 2005, Pages 399-409
Size & Burden of Mental Disorders in Europe
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (177 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.euroneuro.2005.04.009    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2005 Elsevier B.V. and ECNP All rights reserved.

Size of burden of schizophrenia and psychotic disordersstar, open

Wulf Rösslera, Corresponding Author Contact Information, E-mail The Corresponding Author, Hans Joachim Salizeb, Jim van Osc and Anita Riecher-Rösslerd

aPsychiatric University Hospital, Militärstrasse 8, CH-8021 Zurich, Switzerland bCentral Institute of Mental Health, Mannheim, D, Switzerland cDepartment of Psychiatry and Neuropsychology, Maastricht University, NL, Switzerland dUniversity Psychiatric Outpatient Department, University Hospital Basel, CH, Switzerland

Available online 31 May 2005.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Schizophrenia is a severe mental disorder characterised by fundamental disturbances in thinking, perception and emotions. More than 100 years of research have not been able to fully resolve the puzzle that schizophrenia represents. Even if schizophrenia is not a very frequent disease, it is among the most burdensome and costly illnesses worldwide. It usually starts in young adulthood. Life expectancy is reduced by approximately 10 years, mostly as a consequence of suicide. Even if the course of the illness today is considered more favourable than it was originally described, it is still only a minority of those affected, who fully recover. The cumulative lifetime risk for men and women is similar, although it is higher for men in the age group younger than 40 years. According to the Global Burden of Disease Study, schizophrenia causes a high degree of disability, which accounts for 1.1% of the total DALYs (disability-adjusted life years) and 2.8% of YLDs (years lived with disability). In the World Health Report [The WHO World Health Report: new understanding, new hope, 2001. Geneva], schizophrenia is listed as the 8th leading cause of DALYs worldwide in the age group 15–44 years. In addition to the direct burden, there is considerable burden on the relatives who care for the sufferers. The treatment goals for the moment are to identify the illness as early as possible, treat the symptoms, provide skills to patients and their families, maintain the improvement over a period of time, prevent relapses and reintegrate the ill persons into the community so that they can lead as normal a life as possible.

Keywords: Psychosis; Schizophrenia; Epidemiology; Burden; Costs; Gender differences; Early detection

Article Outline

1. Introduction
2. Incidence and prevalence of schizophrenia
3. Course
4. Burden
5. Mortality
6. Burden on patients, families and communities
7. Legal problems
8. Stigma
9. Cost
10. Treatment
11. Early detection
12. Gender issues
13. Discussion
References



European Neuropsychopharmacology
Volume 15, Issue 4, August 2005, Pages 399-409
Size & Burden of Mental Disorders in Europe
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.